DECITABINE — HETERO LABS LTD VI, approved 2024-05-10 (ANDA215355).
4,795 reports across the top reactions. These are spontaneously reported events from the FDA Adverse Event Reporting System — they reflect reporting volume, not incidence or frequency, and a report does not mean the drug caused the event.